MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202641024847 A) filed by Vignan Institute Of Pharmaceutical Technology, Visakhapatnam, Andhra Pradesh, on March 2, for 'blockchain-enabled supply chain tracking for ensuring authenticity of high-value specialty drugs.'
Inventor(s) include M. Lakshmi Banusri; M. Vinod Kumar; K. Priyadarshini Reddy; Bbvm Kishore; and P. Prasanna Kumar.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a blockchain-enabled supply chain tracking system specifically tailored for verifying the authenticity of high-value specialty drugs, such as biologics and orphan medications, throughout their lifecycle from production to patient delivery. This innovative platform leverages distributed ledger technology combined with embedded IoT sensors and cryptographic hashing to create an immutable record of each drug's journey, preventing counterfeiting, diversion, and tampering. By incorporating smart contracts for automated compliance checks and real-time alerts, the system ensures that only genuine products reach end-users, reducing financial losses and health risks associated with fake pharmaceuticals. The integration of a decentralized verification network allows stakeholders, including manufacturers, distributors, pharmacies, and regulators, to access transparent audit trails via a secure web portal, fostering trust and efficiency in the supply chain. This approach not only enhances traceability but also incorporates machine learning algorithms to predict potential vulnerabilities, making it a proactive tool for maintaining drug integrity in global markets."
Disclaimer: Curated by HT Syndication.
